Pharming Group N.V. - stock earnings

PHAR Quarterly earnings

DateEarningsRevenue
2023Q4 -2.7 million USD 81.9 million USD
2023Q3 3.5 million USD 66.7 million USD
2023Q2 1.3 million USD 54.9 million USD
2023Q1 -12.2 million USD 42.5 million USD
2022Q4 -14.6 million USD 54.6 million USD
2022Q3 9.1 million USD 54.2 million USD
2022Q2 15.7 million USD 50.1 million USD
2022Q1 1.9 million USD 45.7 million USD
2021Q4 1.9 million USD 45.7 million USD
2021Q3 -272000 USD 44.6 million USD
2021Q2 5.9 million USD 49.7 million USD
2021Q1 10.6 million USD 70.2 million USD
2020Q4 10.6 million USD 70.2 million USD
2020Q3 9.6 million USD 58.5 million USD
2020Q2 11.1 million USD 45.3 million USD
2020Q1 9.3 million USD 54.4 million USD
2019Q4 14.2 million USD 54.4 million USD
2019Q3 10.9 million USD 46.4 million USD
2019Q2 7.9 million USD 49.1 million USD
2019Q1 7.6 million USD 39.6 million USD
2018Q4 15.0 million USD 40.4 million USD
2018Q3 6.3 million USD 45.5 million USD
2018Q2 3.2 million USD 32.4 million USD
2018Q1 4.1 million USD 36.3 million USD
2017Q4 -51.6 million USD 40.9 million USD
2017Q3 -9.7 million USD 31.6 million USD
2017Q2 -28.4 million USD 18.5 million USD
2017Q1 -6.1 million USD 16.5 million USD
2016Q4 -6.7 million USD 6.9 million USD
2016Q3 -4.2 million USD 3.9 million USD
2016Q2 -3.7 million USD 3.4 million USD
2016Q1 -3.8 million USD 2.5 million USD
2015Q4 -4.2 million USD 2.3 million USD
2015Q3 -2.7 million USD 3.7 million USD
2015Q2 -2.5 million USD 3.9 million USD
2015Q1 -1.4 million USD 1.9 million USD
2014Q4 16.9 million USD 20.9 million USD
2014Q3 3.5 million USD 1.4 million USD
2014Q2 -5.4 million USD 1.5 million USD
2014Q1 -22.1 million USD 2.0 million USD
2013Q4 -5.8 million USD 1.4 million USD
2013Q3 -5.6 million USD 1.7 million USD
2013Q2 -2.4 million USD 5.8 million USD
2013Q1 -7.0 million USD 619813 USD
2012Q4 -814495 USD 11.1 million USD
2012Q3 -10.1 million USD 653268 USD
2012Q2 -12.3 million USD 1.1 million USD
2012Q1 -8.7 million USD 1.2 million USD
2011Q4 -4.1 million USD 969612 USD
2011Q3 -6.6 million USD 1.0 million USD
2011Q2 -6.5 million USD 999961 USD
2011Q1 -5.1 million USD 897975 USD
2010Q4 -27.8 million USD -151010 USD
2010Q3 -9.0 million USD 361143 USD
2010Q2 -23.8 million USD 215599 USD
2010Q1 -10.3 million USD 277893 USD
2009Q4 -12.1 million USD 792724 USD
2009Q3 -11.7 million USD 267974 USD
2009Q2 -12.9 million USD 350266 USD
2009Q1 -8.2 million USD 137976 USD

PHAR Yearly earnings

DateEarningsRevenue
2023 -22.1 million USD 218.7 million USD
2022 13.7 million USD 205.6 million USD
2021 16.0 million USD 189.9 million USD
2020 37.7 million USD 228.4 million USD
2019 40.5 million USD 189.3 million USD
2018 28.6 million USD 154.6 million USD
2017 -95.9 million USD 107.5 million USD
2016 -18.4 million USD 16.7 million USD
2015 -10.9 million USD 11.8 million USD
2014 -7.0 million USD 25.8 million USD
2013 -20.8 million USD 9.5 million USD
2012 -31.9 million USD 14.0 million USD
2011 -22.2 million USD 3.9 million USD
2010 -75.0 million USD 762069 USD
2009 -45.9 million USD 1.6 million USD
2008 -36.5 million USD 924353 USD
2007 -51.9 million USD 1.0 million USD
2006 -24.4 million USD 194010 USD
2005 -21.2 million USD 479681 USD

PHAR

Price: $10.45

52 week price:
9.33
16.71

Earnings Per Share: -0.33 USD

P/E Ratio: -40.74

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1500

Market Capitalization: 713.0 million

Average Dividend Frequency: 1

Links: